Is the price fair?
What ALHC's price assumes
Alignment Healthcare, Inc. trades at 70.8× earnings against 25.6× for the median Healthcare Plans name, more expensive than its own group.
70.8
Trailing P/E · Healthcare Plans median 25.6 · 2.77× the median: the market pays up for this one
- Price / sales
- 0.88
Price / sales · as of 2026-Q1
- Free cash flow yield
- 3.8%
Free cash flow yield · Healthcare Plans median 6.5%
- Growth the price implies
- +9.3%
Growth the price implies · The price pays for +9.3% free cash flow growth a year for a decade; the business has delivered +57% a year over the last three.
Details›
- Price / book2026-Q1
- 18.1
- EV / EBIToperating margin 1.2%: the multiple describes the denominator
- not meaningful
- EV / sales2026-Q1
- 0.79
- Healthcare median P/E362 names
- 29.9
- Healthcare Plans median P/E11 names
- 25.6
- Free cash flow, trailing twelve months
- $178M
- Market capitalisation
- $4.69B
- 3-year revenue growth
- +41%
- 3-year free cash flow growth
- +57%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Healthcare
Ranks #303 of 345 by Smart Score